European shares rise, Genmab jumps on drug trial results, bond yields dip
European shares climbed towards one-week highs, led by gains in healthcare stocks after Genmab announced upbeat drug-trial results. Euro zone bond yields stabilized after recent gains driven by fiscal and inflation concerns.